We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Coastal Financial
CCB
$1.11B
| $1.65M | 0.01% |
15,276
-819
| -5% | -$86.8K |
|
627
Paysign
PAYS
$510M
| $1.64M | 0.01% |
+260,758
| New | +$1.67M |
|
|
CLDT
628
Chatham Lodging
CLDT
$638M
| $1.64M | 0.01% |
244,171
-22,053
| -8% | -$158K |
|
629
Enovix
ENVX
$866M
| $1.63M | 0.01% |
163,402
+143,501
| +721% | +$1.59M |
|
630
OmniAb
OABI
$286M
| $1.61M | 0.01% |
1,006,256
-99,268
| -9% | -$181K |
|
631
S&T Bancorp
STBA
$1.92B
| $1.6M | 0.01% |
42,691
-24,401
| -36% | -$938K |
|
632
Meritage Homes
MTH
$4.89B
| $1.6M | 0.01% |
22,152
-732,213
| -97% | -$54.4M |
|
633
PACS Group
PACS
$7.43B
| $1.6M | 0.01% |
116,475
-82,311
| -41% | -$966K |
|
634
Capital City Bank Group
CCBG
$904M
| $1.58M | 0.01% |
37,789
-48
| -0.1% | -$2K |
|
635
South Plains Financial
SPFI
$855M
| $1.57M | 0.01% |
40,650
-2,589
| -6% | -$101K |
|
636
Ibotta
IBTA
$634M
| $1.57M | 0.01% |
+56,368
| New | +$1.77M |
|
637
Atlanticus Holdings
ATLC
$1.58B
| $1.56M | 0.01% |
26,622
-10,513
| -28% | -$635K |
|
638
Travelzoo
TZOO
$77.8M
| $1.55M | 0.01% |
157,872
-9,469
| -6% | -$102K |
|
639
AudioEye
AEYE
$75.8M
| $1.54M | 0.01% |
111,232
-2,765
| -2% | -$34.4K |
|
640
RPC Inc
RES
$1.14B
| $1.54M | 0.01% |
323,603
-540,450
| -63% | -$2.55M |
|
|
FFIC
641
DELISTED
Flushing Financial
FFIC
| $1.52M | 0.01% |
109,984
+3,077
| +3% | +$40K |
|
642
Neumora Therapeutics
NMRA
$311M
| $1.51M | 0.01% |
+830,818
| New | +$1.34M |
|
643
Coty
COTY
$2.45B
| $1.51M | 0.01% |
374,239
-4,895
| -1% | -$22.4K |
|
644
DMC Global
BOOM
$112M
| $1.51M | 0.01% |
178,671
-40,967
| -19% | -$307K |
|
645
Innoviva
INVA
$1.61B
| $1.49M | 0.01% |
81,690
-9,556
| -10% | -$186K |
|
646
Voya Financial
VOYA
$9.07B
| $1.47M | 0.01% |
19,670
| – | – |
|
647
KRONOS Worldwide
KRO
$712M
| $1.46M | 0.01% |
255,019
-93,586
| -27% | -$567K |
|
648
Torrid Holdings
CURV
$271M
| $1.45M | 0.01% |
+830,512
| New | +$1.91M |
|
649
Mistras Group
MG
$490M
| $1.45M | 0.01% |
147,146
-76,782
| -34% | -$683K |
|
650
Rigel Pharmaceuticals
RIGL
$712M
| $1.44M | 0.01% |
50,746
-164,887
| -76% | -$4.93M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.